Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The capsid proteins of poliovirus types 1, 2, and 3 are the structural proteins that form the outer shell (capsid) of the poliovirus particle. These proteins are critical for protecting the viral RNA genome and mediating interactions with host cells during infection. The capsid is composed of 60 copies each of VP1, VP2, VP3, and VP4. VP1 interacts directly with the host cell receptor PVR/CD155 to mediate attachment to target epithelial cells. The capsid proteins determine cellular tropism and antigenicity, which is the basis for vaccine development.
Vaccines induce neutralizing antibodies that bind to the capsid proteins and prevent viral attachment and entry into host cells.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus Type 1, 2, and 3 Capsid Protein.